Fence Post Spikes Great Yarmouth

Acid Extractable Matrix Spikes
CLPS-MSA15-TI 1ML
EUR 52.8

Human IgG antibody Laboratories manufactures the fence post spikes great yarmouth reagents distributed by Genprice. The Fence Post Spikes Great Yarmouth reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike S. Other Fence products are available in stock. Specificity: Fence Category: Post Group: Spikes Great

Blades Post Mortem For INS4456
PK10
EUR 28.8

True north Cryobox 0.2mLNatural
PK10
EUR 172.8

True north Cryobox 0.5mLNatural
PK10
EUR 153.6

True north Cryobox1.5/2mLNatural
PK10
EUR 100.8

True north Cryobox 5mLNatural
PK10
EUR 153.6

True north Cryobox 5mLBlue
PK10
EUR 153.6

True north Cryobox 15mLNatural
PK10
EUR 212.4

Spikes Great information

Mouse Post- GPI attachment to proteins factor 3, Pgap3 ELISA KIT
ELI-12322m 96 Tests
EUR 1038

VAHTS Target Capture Universal Blockers and Post-PCR Primer Mix for MGI-SI
NCM101-01 24 rxns
EUR 528

VAHTS Target Capture Universal Blockers and Post-PCR Primer Mix for MGI-SI
NCM101-02 96 rxns
EUR 1751.2

VAHTS Target Capture Universal Blockers and Post-PCR Primer Mix for Illumina-TS
NC101-01 24 rxns
EUR 528

VAHTS Target Capture Universal Blockers and Post-PCR Primer Mix for Illumina-TS
NC101-02 96 rxns
EUR 1751.2

Recombinant SARS-COV-2 S1+S2 ECD(S-ECD) Protein with His tag (Post-Fusion)
E80030-1 100 ul Ask for price

Spike S1 (16-685), Fc fusion (SARS-CoV-2)
100688-1 20 µg
EUR 405
Description: SARS-CoV-2 2019-nCoV Spike protein S1, also known as SARS-CoV s1 and coronavirus spike S1, GenBank Accession No. QHD43416.1, a.a. 16-685, with C-terminal Fc-tag, expressed in a CHO cell expression system. MW= 160 kDa.

Spike S1 (16-685), Avi-His-tag (SARS-CoV-2)
100730-1 100 µg
EUR 320
Description: Severe acute respiratory Coronavirus 2 Spike Glycoprotein S1 (SARS-CoV-2 Spike S1), GenBank Accession No. QHD43416.1, a.a. 16-685 with a C-terminal Avi-His-tag, expressed in a HEK293 expression system, MW=78 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation.

Spike S1 (16-685), Avi-His-tag (SARS-CoV-2)
100730-2 1 mg
EUR 2720
Description: Severe acute respiratory Coronavirus 2 Spike Glycoprotein S1 (SARS-CoV-2 Spike S1), GenBank Accession No. QHD43416.1, a.a. 16-685 with a C-terminal Avi-His-tag, expressed in a HEK293 expression system, MW=78 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation.

Spike S1 (13-665), Fc Fusion, Avi-tag (SARS-CoV-2)
100678-1 100 µg
EUR 350
Description: Severe acute respiratory Coronavirus 2 Spike Glycoprotein S1 (SARS-CoV-2 Spike S1), GenBank Accession No. QHD43416.1, a.a. 13-665, fused at the C-terminus of the Fc portion of human IgG1, with a C-terminal Avi-tag™, expressed in a HEK293 expression system, MW=102 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation.

Spike S1 (13-665), Fc Fusion, Avi-tag (SARS-CoV-2)
100678-2 1 mg
EUR 3000
Description: Severe acute respiratory Coronavirus 2 Spike Glycoprotein S1 (SARS-CoV-2 Spike S1), GenBank Accession No. QHD43416.1, a.a. 13-665, fused at the C-terminus of the Fc portion of human IgG1, with a C-terminal Avi-tag™, expressed in a HEK293 expression system, MW=102 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation.

Spike S1 (16-685), Fc Fusion, Avi-tag (SARS-CoV-2)
100719-1 100 µg
EUR 320
Description: Severe acute respiratory Coronavirus 2 Spike Glycoprotein S1 (SARS-CoV-2 Spike S1), GenBank Accession No. QHD43416.1, a.a. 16-685, fused at the C-terminus of the Fc portion of human IgG1, with a C-terminal Avi-tag™, expressed in a HEK293 expression system, MW=104 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation.

Spike S1 (16-685), Fc Fusion, Avi-tag (SARS-CoV-2)
100719-2 1 mg
EUR 2720
Description: Severe acute respiratory Coronavirus 2 Spike Glycoprotein S1 (SARS-CoV-2 Spike S1), GenBank Accession No. QHD43416.1, a.a. 16-685, fused at the C-terminus of the Fc portion of human IgG1, with a C-terminal Avi-tag™, expressed in a HEK293 expression system, MW=104 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation.

SARS-CoV-2 Spike S1 (16-685) Protein, Avi-His-tag
E80021
  • EUR 635.80
  • EUR 4276.80
  • 100 ul
  • 1 ml

SARS-CoV-2 (COVID-19) Spike 156-157EF Antibody
9685-002mg 0.02 mg
EUR 229.7
Description: SARS-CoV-2 delta variant, a variant of concern (VOC), known as B.1.617.2, was detected in India in October of 2020. However, it rapidly spread all over of the world and now it is the dominant variant in the world, which account for more than 99% of the cases. This variant carries at least 13 mutations in spike protein across the sub lineages, including L452R, D614G, P681R and K417N, which can increase the affinity to the human ACE2 receptor. Enhanced transmission of the Delta variant was observed globally, which is at least 2.5 times more contagious as the other variants. The Delta variant affects the effectiveness of COVID19 vaccine and is resistant to neutralization to some extent.

SARS-CoV-2 (COVID-19) Spike 156-157EF Antibody
9685-01mg 0.1 mg
EUR 594.26
Description: SARS-CoV-2 delta variant, a variant of concern (VOC), known as B.1.617.2, was detected in India in October of 2020. However, it rapidly spread all over of the world and now it is the dominant variant in the world, which account for more than 99% of the cases. This variant carries at least 13 mutations in spike protein across the sub lineages, including L452R, D614G, P681R and K417N, which can increase the affinity to the human ACE2 receptor. Enhanced transmission of the Delta variant was observed globally, which is at least 2.5 times more contagious as the other variants. The Delta variant affects the effectiveness of COVID19 vaccine and is resistant to neutralization to some extent.

SARS-CoV-2 Spike S1 (13-665) Protein, Fc Fusion, Avi-tag
E80020
  • EUR 635.80
  • EUR 4276.80
  • 100 ul
  • 1 ml